查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386580

間質性血管細胞群體市場報告：2030 年趨勢、預測與競爭分析

Stromal Vascular Fraction Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

間質血管細胞群的趨勢與預測

2030年，全球基質血管細胞群市場預計將達到1.23億美元，2024年至2030年的年複合成長率為5.1%。該市場的主要促進因素包括骨骼和肌肉疾病盛行率的增加、對幹細胞治療的認知和知識的增加、再生醫學的發展以及大量的臨床前和臨床研究工作。全球基質血管細胞群市場的未來充滿希望，醫院、專科診所和幹細胞庫/實驗室市場充滿機會。

間質血管細胞群市場洞察

Lucintel 預測，在預測期內，軟組織應用仍將是最大的細分市場。

由於私人醫療機構的持續擴張，包括農村地區私立醫院數量的增加，亞太地區在預測期內將繼續成為最大的地區。基質血管部分將受益於持續的研究和開發舉措，刺激最尖端科技的發展和不斷成長的需求。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2. 哪個產業將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球基質血管細胞群市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球基質血管細胞群市場趨勢（2018-2023）與預測（2024-2030）
  • 全球基質血管細胞群市場（按產品）
    • SVF 抽吸產品
    • SVF傳輸產品
    • SVF絕緣產品
  • 全球基質血管細胞群市場（依應用）
    • 化妝品應用
    • 整形外科應用
    • 應用於軟組織
    • 其他
  • 以最終用途分類的全球基質血管細胞組​​市場
    • 醫院
    • 專科診所
    • 幹細胞庫/實驗室
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的全球基質血管細胞群市場
  • 北美基質血管細胞群市場
  • 歐洲基質血管細胞群市場
  • 亞太基質血管細胞群市場
  • 其他區域基質血管細胞市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球基質血管細胞組​​市場成長機會（按產品）
    • 全球基質血管細胞群市場成長機會（依應用）
    • 全球基質血管細胞組​​市場成長機會（依最終用途）
    • 全球基質血管細胞組​​市場成長機會（按地區）
  • 全球基質血管細胞群市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球基質血管細胞群市場的容量
    • 全球基質血管細胞群市場的合併、收購與合資企業
    • 認證和許可

第7章 主要企業概況

  • Cytori Therapeutics
  • IntelliCell BioSciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • InGeneron
  • Human med
  • Hairline International
  • Genesis Biosystems
  • Kyocera
簡介目錄

Stromal Vascular Fraction Trends and Forecast

The future of the global stromal vascular fraction market looks promising with opportunities in the hospital, specialty clinic, and stem cell banks/laboratory markets. The global stromal vascular fraction market is expected to reach an estimated $123 million by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of skeletal and muscular ailments, growing recognition and knowledge regarding stem cell therapy, increasing movement towards regenerative medicine, and numerous pre-clinical and clinical research endeavors.

A more than 150-page report is developed to help in your business decisions.

Stromal Vascular Fraction by Segment

The study includes a forecast for the global stromal vascular fraction by product, application, end use, and region.

Stromal Vascular Fraction Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • SVF Aspiration Products
  • SVF Transfer Products
  • SVF Isolation Products

Stromal Vascular Fraction Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cosmetic Applications
  • Orthopedic Applications
  • Soft Tissue Applications
  • Others

Stromal Vascular Fraction Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Specialty Clinics
  • Stem Cell Banks/Laboratories
  • Others

Stromal Vascular Fraction Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stromal Vascular Fraction Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stromal vascular fraction companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stromal vascular fraction companies profiled in this report include-

  • Cytori Therapeutics
  • Intellicell Biosciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • Ingeneron
  • Human Med
  • Hairline International
  • Genesis Biosystems
  • Kyocera

Stromal Vascular Fraction Market Insights

Lucintel forecasts that soft tissue application will remain the largest segment over the forecast period.

APAC will remain the largest region over the forecast period due to ongoing expansion of private healthcare facilities, including a rising number of private hospitals in rural regions, stromal vascular fraction stands to benefit from ongoing research and development initiatives, spurred by the growing development and demand for cutting-edge technologies.

Features of the Global Stromal Vascular Fraction Market

Market Size Estimates: Stromal vascular fraction market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stromal vascular fraction market size by product, application, end use, and region in terms of value ($M).

Regional Analysis: Stromal vascular fraction market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and regions for the stromal vascular fraction market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stromal vascular fraction market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the stromal vascular fraction market size?

Answer: The global stromal vascular fraction market is expected to reach an estimated $123 million by 2030.

Q.2 What is the growth forecast for stromal vascular fraction market?

Answer: The global stromal vascular fraction market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the stromal vascular fraction market?

Answer: The major drivers for this market are increasing prevalence of skeletal and muscular ailments, growing recognition and knowledge regarding stem cell therapy, increasing movement towards regenerative medicine, and numerous pre-clinical and clinical research endeavors.

Q4. What are the major segments for stromal vascular fraction market?

Answer: The future of the global stromal vascular fraction market looks promising with opportunities in the hospital, specialty clinic, and stem cell banks/laboratory markets.

Q5. Who are the key stromal vascular fraction market companies?

Answer: Some of the key stromal vascular fraction companies are as follows:

  • Cytori Therapeutics
  • Intellicell Biosciences
  • Cellular Biomedicines Group
  • Lifecell
  • Tissue Genesis
  • Ingeneron
  • Human Med
  • Hairline International
  • Genesis Biosystems
  • Kyocera

Q6. Which stromal vascular fraction market segment will be the largest in future?

Answer: Lucintel forecasts that soft tissue application will remain the largest segment over the forecast period.

Q7. In stromal vascular fraction market, which region is expected to be the largest in next 5 years?

Answer: APAC will remain the largest region over the forecast period due to ongoing expansion of private healthcare facilities, including a rising number of private hospitals in rural regions, stromal vascular fraction stands to benefit from ongoing research and development initiatives, spurred by the growing development and demand for cutting-edge technologies.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the stromal vascular fraction market by product (SVF aspiration products, SVF transfer products, and SVF isolation products), application (cosmetic applications, orthopedic applications, soft tissue applications, and others), end use (hospitals, specialty clinics, stem cell banks/laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stromal Vascular Fraction Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Stromal Vascular Fraction Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Stromal Vascular Fraction Market by Product
    • 3.3.1: SVF Aspiration Products
    • 3.3.2: SVF Transfer Products
    • 3.3.3: SVF Isolation Products
  • 3.4: Global Stromal Vascular Fraction Market by Application
    • 3.4.1: Cosmetic Applications
    • 3.4.2: Orthopedic Applications
    • 3.4.3: Soft Tissue Applications
    • 3.4.4: Others
  • 3.5: Global Stromal Vascular Fraction Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Specialty Clinics
    • 3.5.3: Stem Cell Banks/Laboratories
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Stromal Vascular Fraction Market by Region
  • 4.2: North American Stromal Vascular Fraction Market
    • 4.2.1: North American Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.2.2: North American Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.3: European Stromal Vascular Fraction Market
    • 4.3.1: European Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.3.2: European Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.4: APAC Stromal Vascular Fraction Market
    • 4.4.1: APAC Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.4.2: APAC Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
  • 4.5: ROW Stromal Vascular Fraction Market
    • 4.5.1: ROW Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
    • 4.5.2: ROW Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stromal Vascular Fraction Market by Product
    • 6.1.2: Growth Opportunities for the Global Stromal Vascular Fraction Market by Application
    • 6.1.3: Growth Opportunities for the Global Stromal Vascular Fraction Market by End Use
    • 6.1.4: Growth Opportunities for the Global Stromal Vascular Fraction Market by Region
  • 6.2: Emerging Trends in the Global Stromal Vascular Fraction Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stromal Vascular Fraction Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stromal Vascular Fraction Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Cytori Therapeutics
  • 7.2: IntelliCell BioSciences
  • 7.3: Cellular Biomedicines Group
  • 7.4: Lifecell
  • 7.5: Tissue Genesis
  • 7.6: InGeneron
  • 7.7: Human med
  • 7.8: Hairline International
  • 7.9: Genesis Biosystems
  • 7.10: Kyocera